Keyphrases
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9)
100%
Ovarian Cancer
35%
Liver
35%
Acute Phase Reactants
35%
MTOR Inhibitor
33%
Cancer Metabolism
33%
Ovarian Cancer Cells
33%
Targeted Therapy
33%
Cancer Cell Survival
21%
Patient-derived Cell Culture
20%
Zebrafish
15%
PCSK9 Expression
13%
Ovarian Cancer Patients
13%
Drug Response
13%
Malignancy
10%
Pro-survival
10%
Small Interfering RNA (siRNA)
8%
Acute Phase Response
8%
Lipid Metabolism
8%
Metabolic Pathway
6%
Small Molecule Libraries
6%
ERK2
6%
Metabolic
6%
Metabolic Heterogeneity
6%
Lipogenesis
6%
Dysregulated Lipid Metabolism
6%
Cytotoxic Efficacy
6%
Akt Phosphorylation
6%
Omentum
6%
Cytotoxic Response
6%
Omental Metastasis
6%
Metabolic Gene Expression
6%
Low-grade Serous Ovarian Cancer
6%
Metastatic Ovarian Cancer
6%
Specific Inhibitor
6%
Drug Target
6%
Overexpression
6%
High-grade Serous Ovarian Cancer (HGSOC)
6%
Drug Testing
6%
Tion
6%
Therapeutic Value
6%
Downstream Signaling
6%
Gene Response
6%
Ovarian Cancer Subtypes
6%
Cholesterol
6%
MEK1
6%
Vulnerability
6%
Lipid-rich
6%
Mammalian Target of Rapamycin (mTOR)
6%
Gene Drug
6%
Immunology and Microbiology
Zebra Fish
66%
Acute Phase Protein
44%
Streptococcus Pneumonia
28%
Acute Phase Response
26%
Cell Line
24%
Cancer Cell
22%
Lipid Metabolism
22%
CRISPR/Cas9
17%
Pneumococcus
13%
Immune Response
11%
Intracellular Signaling
11%
Cholesterol Transport
11%
DNA Modification
11%
Cell Proliferation
11%
Immune-Related Gene
11%
C-Reactive Protein
11%
Nervous System Development
11%
Ontogeny
11%
Ascites Fluid
11%
Immortalised Cell Line
11%
Major Histocompatibility Complex
11%
Cancer Cell Culture
11%
Protein Expression
11%
Cell Survival
11%
Gene Expression
11%
Gene Knockout
11%
Gene Targeting
11%
Low-Density Lipoprotein
11%
Immunoregulation
6%
Mutagenesis
6%
Transcriptomics
6%
Innate Immune System
6%
Cholesterol Blood Level
6%
Antimicrobial Peptides
6%
Complement
6%
Cytokine Production
6%
Gene Expression Assay
6%
Medicine and Dentistry
Malignant Neoplasm
36%
Ovarian Cancer
35%
Targeted Therapy
33%
Proprotein Convertase 9
33%
Cancer Metabolism
33%
Isocitrate Dehydrogenase
33%
Cancer Cell
15%
Cell Survival
10%
Lipid Metabolism
9%
Cell Culture
8%
Cancer
6%
